KHN922

KHN922 · Chengdu Kanghong Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KHN922, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: First-In-Human Study of KHN922 for Injection [Phase 1, Phase 2]